COVID-19 Diagnostics

Home  /  COVID-19 Diagnostics

This section is dedicated to rapid collaborative reviews and HTA reports on diagnostic tests for the detection of SARS-CoV-2 requested to inform timely national policy/decision-making.

 

EUnetHTA Rapid Collaborative Reviews

 

Project IDTitlePublication of Final ReviewAuthorCo-AuthorPublication of Project Plan
RCROT01Rapid Collaborative Review on the role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic23.06.2020RERIQWiG, HTW12.05.2020
RCROT02Diagnostic accuracy of molecular methods that detect the presence of SARS-CoV-2 virus in people with suspected COVID-1917.11.2020HTWHIS, Austrian Social Insurance – Dachverband der Sozialversicherungsträger (formerly HVB)31.07.2020 (revised 08.10.2020)

 

National HTA Organisation Reports

 

CountryOrganisationDate of publicationHTA reviews/assessments on Covid testing
UKNICE
n.d.Evidence standards framework for SARS-CoV-2 and anti-SARS-CoV-2 antibody diagnostic tests
NorwayNIPHNO (formerly NOKC)
n.d.NIPH systematic and living map on COVID-19 evidence (including lab tests)
ItalyAIFA
n.d.Eparine a basso peso molecolare nei pazienti adulti con COVID-19 (Low molecular weight heparins in adult patients with COVID-19)
SpainAEMPS
10/23/20Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19 (Suspected adverse reactions reported with treatments used in COVID-19)
ItalyAIFA
10/6/20Corticosteroidi nella terapia dei pazienti adulti con COVID-19 (Corticosteroids in the therapy of adult patients with COVID-19)
SpainAEMPS
10/6/20Información sobre investigación clínica sobre la COVID-19 (Information on clinical research on COVID-19)
FranceHAS
9/25/20Veille des études cliniques publiées pour certains médicaments du Covid-19 (Monitors published clinical studies for certain Covid-19 drugs)
SpainAQuAS9/22/20
Símptomes de llarga durada o persistents en pacients amb infecció lleu-moderada per SARS-CoV-2 (COVID-19): revisió ràpida de la literatura i discussió del’evidència disponible (Long-term or persistent symptoms in patients with moderate SARS-CoV-2 infection (COVID-19): rapid literature review and discussion of available evidence )
ItalyAIFA
9/18/20Remdesivir nella terapia dei pazienti adulti con COVID-19 (Remdesivir in the therapy of adult patients with COVID-19)
IrelandNCPE9/2/20Rapid Evidence Review - Clinical evidence for the use of antivirals in the treatment of COVID-19
PolandAOTMiT8/28/20Tocilizumab in the management of patients who have severe COVID-19 infection with suspected hyperinflammation
IrelandNCPE
8/21/20Tocilizumab in the management of patients who have severe COVID-19 infection with suspected hyperinflammation
AustriaAIHTA
8/18/20COVID-19/Horizon Scanning Living Document
FinlandFIMEA
8/7/20Fimea julkaisi arviointikoosteen remdesiviiristä COVID-19-taudin hoidossa (Fimea has published a summary of the evaluation of remdesivirir in the treatment of COVID-19)
PolandAOTMIT
8/6/20Przegląd doniesień naukowych dla kortykosteroidów stosowanych w COVID-19 (Assessment of the scientific reports for corticosteroids used in COVID-19 (version 1.0))
PolandAOTMIT
8/5/20Przegląd doniesień naukowych dla lopinawiru/rytonawiru stosowanych w COVID-19 (Overview of the scientific reports for lopinavir / ritonavir used in COVID-19 (version 1.0))
SpainAEMPS
8/3/20Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19 (Suspected adverse reactions reported with treatments used in COVID-19)
ItalyAIFA
7/22/20Idrossiclorochina nella terapia dei pazienti adulti con COVID-19 (Hydroxychloroquine in the treatment of adult patients with COVID-19)
ItalyAIFA
7/17/20Darunavir/cobicistat nella terapia dei pazienti adulti con COVID-19 (Darunavir / cobicistat in the treatment of adult patients with COVID-19 )
ItalyAIFA
7/17/20 Lopinavir/ritonavir nella terapia dei pazienti adulti con COVID-19 (Lopinavir / ritonavir in the treatment of adult patients with COVID-19 )
ItalyAIFA7/17/20Farmaci utilizzabili per il trattamento della malattia COVID-19 (Drugs usable for the treatment of the disease COVID-19)
WalesHTW7/??/20Cytokine adsorbers for the treatment of cytokine
storm in people with severe coronavirus infection
PortugalINFARMED National Authority of Medicines and Health Products7/1/20Informação adicional para utilização do teste "GeneFinder COVID-19 Plus RealAmp Kit" (Additional information for using the "GeneFinder COVID-19 Plus RealAmp) Kit" test)
PortugalINFARMED National Authority of Medicines and Health Products7/1/20Comercialização descontinuada do teste "BIOEASY 2019 - Novel Coronavirus (2019-nCoV) Ag GICA Rapid Test" (Discontinued commercialization of the test "BIOEASY 2019 - Novel Coronavirus (2019-nCoV) Ag GICA Rapid Test")
SpainDGFPS MSPSI
Directorate General for Pharmacy and Health Care Products
s
6/30/20Instrucciones sobre la realización de pruebas diagnósticas para la detección del Covid-19 en el ámbito de las empresas (Instructions on carrying out diagnostic tests for the detection of COVID-19 in companies)
UKNICE National Institute for Health and Care Excellence6/29/20COVID-19 rapid evidence summary: vitamin D for COVID-19
SpainAVALIA FNS
Fundacion Profesor Novoa Santos
6/29/20Estudios seleccionados sobre SARS-CoV-2 y COVID-19 (Selected studies on SARS-CoV-2)
FinlandTHL National Institute for Health and Welfare6/26/20Koronaviruksen COVID-19 laboratoriotutkimukset - Mikrobiologiset tutkimukset uuden koronaviruksen (SARS-CoV-2) epäilyssäLaboratory studies of coronavirus COVID-19 (Microbiological studies on suspicion of a novel coronavirus (SARS-CoV-2))
IrelandHIQA
Health Information and Quality Authority

6/23/20Evidence summary for salivary detection of SARS-CoV-2
SpainAVALIA-T
Galician Agency for HTA

6/19/20Estudios seleccionados sobre SARS-CoV-2 y COVID-19, Categoría: Diagnósticos (Selected studies on SARS-CoV-2 and COVID-19, Category: Diagnostics)
PortugalINFARMED
National Authority of Medicines and Health Products

6/12/20Retificação - Recolha voluntária de lote do teste Tell Me Fast Rapid Diagnostic Test Coronavirus (COVID-19) IgG/IgM Antibody Test (S/P/WB) - fabricante Biocan Diagnostics Inc (Rectification - Voluntary batch collection of the Tell Me Fast Rapid Diagnostic Test Coronavirus)
UKNICE
National Institute for Health and Care Excellence

6/5/20COVID 19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19
SpainAETS-ISCIII
The Instituto De Salud Carlos III

6/1/20Deteccion de SARS-CoV-2 en aguas residuales como herramienta de vigilancia y alerta rápida (detection of SARS-CoV-2 in wastewater as a surveillance tool and quick alert)
NorwayNIPHNO (formerly NOKC)
The Norwegian Institute of Public Health

5/31/20Saliva sampling for testing SARS-CoV-2 infection - a rapid review
NorwayNIPHNO (formerly NOKC)
The Norwegian Institute of Public Health

5/29/20Serology and rapid tests
PortugalINFARMED
National Authority of Medicines and Health Products

5/28/20Testes laboratoriais para SARS-CoV-2, Testes Rápidos (Laboratory tests for SARS-CoV-2, Rapid Tests)
PortugalDGS / INFARMED / INSA Joint Information
5/27/20Testes Laboratoriais para SARS-CoV-2; Testes Rápidos (Laboratory Tests for SARS-CoV-2; Rapid Tests, Joint information)
SpainAETS-ISCIII
The Instituto De Salud Carlos III

5/24/20Interpretación de las pruebas diagnósticas frente a SARS-CoV-2 (Interpretation of diagnostic evidence against SARS-CoV-2)
UkraineMoH Ukraine
5/22/20Застосування ліків при COVID-19 (The use of drugs in COVID-19)
NorwayNIPHNO (formerly NOKC)
The Norwegian Institute of Public Health

5/22/20Molecular diagnostics of sars-Cov-2
SpainAETSA
Andalusian HTA Agency

5/21/20Exactitud diagnóstica de la muestra de saliva para la detección de SARS-CoV-2. NIPH (Saliva sample for testing SARS-CoV-2 infection – a rapid review)
FranceHAS5/20/20Avis n° 2020.0033/AC/SEAP du 20 mai 2020 du collège de la Haute Autorité de santé relatif à l’inscription sur la liste des actes et prestations mentionnée à l’article L. 162-1-7 du code de la sécurité sociale, de la détection des anticorps sériques dirigés contre le coronavirus SARS-CoV-2 (Opinion of the college of the HAS relating to the inscription on the list of acts and services mentioned in article L. 162-1-7 of the social security code , detection of serum antibodies against SARS-CoV-2 coronavirus)
SlovakiaMoH Slovak Republic
Ministry of Health of the Slovak Republic

5/19/20Klinický protokol indikácií testovania metódou PCR na dôkaz SARS-CoV-2 (verzia 9 dátum: 19.5.2020) (Clinical protocol for indications for PCR testing for SARS-CoV-2)
SpainDGFPS MSPSI
Directorate General for Pharmacy and Health Care Products
s

5/18/20Toma y transporte de muestras para diagnóstico por PCR de SARS-CoV-2 (Guide for taking and transporting samples for SARS-CoV-2 PCR diagnosis)
HungaryNIPN
National Institute of Pharmacy and Nutrition

5/15/20Tájékoztatás SARS-CoV-2 (COVID-19) fertőzöttség kimutatására szánt gyorstesztekről és az önellenőrzési, laikusok általi (otthoni) tesztelési célra forgalomba hozható tesztek forgalmazásának és a kereskedelmi kommunikáció jogszerűségének egyes kérdéseiről (Information on rapid tests for the detection of SARS-CoV-2 (COVID-19) infection and on certain issues concerning the marketing of self-monitoring tests that can be placed on the market for lay (home) testing and the legality of commercial communications)
FranceHAS5/14/20Avis n° 2020.0032/AC/SBPP du 14 mai 2020 du collège de la Haute Autorité de santé portant sur les modalités de dépistage du virus SARS-CoV-2 chez les patients admis en établissement de santé (Opinion of the college of the HAS relating to the methods of detection of the virus SARS-CoV-2 in the patients admitted in health establishment)
UKAWTTC
All Wales Therapeutics and Toxicology Centre

5/14/20The clinical effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis
PortugalINFARMED
National Authority of Medicines and Health Products

5/11/20Falsificação de testes rápidos para COVID-19 (Counterfeit rapid tests for COVID-19)
SpainAETS-ISCIII
The Instituto De Salud Carlos III

5/7/20Guía para la utilización de tests rápidos de anticuerpos para covid-19 (Guide to the use of quick tests of antibodies for covid-19)
FranceHAS5/6/20Avis n°2020.0020/AC/SEAP du 6 mars 2020 du collège de la HAS relatif à l’inscription sur la LAP mentionnée à l’article L. 162-1-7 du CSS, de la détection du génome du coronavirus SARS-CoV-2 par technique de transcription inverse suivie d’une amplification (Opinion of the college of the HAS relating to the registration on the LAP mentioned in article L. 162-1-7 of the CSS, of the detection of the genome of the coronavirus SARS-CoV -2 by reverse transcription technique followed by amplification)
IrelandHIQA
Health Information and Quality Authority

5/5/20Rapid HTA of alternative diagnostic testing for coronavirus 2 (SARS-CoV-2)
FranceHAS5/2/20Place des tests sérologiques dans la stratégie de prise en charge de la maladie COVID-19 (Place of serological tests in the COVID-19 management strategy)
PolandAOTMiT
Agency for Health Technology Assessment and Tariff System
4/25/20COVID-19 recommendations: Polish diagnostic, therapeutic and organisational recommendations for the care of individuals infected with SARS-CoV-2 or exposed to a SARS-CoV-2 infection
SlovakiaMoH Slovak Republic Ministry of Health of the Slovak Republic4/25/20Štandardný postup pre mikrobiologickú diagnostiku pri suspektnej infekcii vírusom SARS-CoV2 pre laboratóriá klinickej mikrobiológie (Standard Procedure for Microbiological Diagnosis of Suspected SARS-CoV2 Virus Infection for Clinical Microbiology Laboratories)
PortugalACSS IP
Administração Central do Sistema de Saúde, I.P.

4/24/20COVID-19: Diagnóstico Laboratorial (COVID-19: Laboratory Diagnosis)
PolandAOTMiT
Agency for Health Technology Assessment and Tariff System

4/21/20Analiza kosztów wykonania testów na obecność wirusa SARS-CoV-2 (Analysis of the costs of testing for the presence of SARS-CoV-2 virus)
ItalyRER
Regione Emilia-Romagna
4/16/20Covid-19: Disciplina die test sierologici (Serological test discipline)
SlovakiaMoH Slovak Republic Ministry of Health of the Slovak Republic4/15/20Štandardný preventívny, diagnostický a terapeutický postup pri starostlivosti o kriticky chorých s COVID-19 (Standard preventive, diagnostic and therapeutic procedure for the care of critically ill patients with COVID-19)
IrelandHIQA Health Information and Quality Authority4/15/20Evidence Summary for COVID-19 Clinical Samples
NorwayHdir Norwegian Directorate of Health4/14/20Hvordan øke testkapasiteten for SARS-CoV-2 i Norge? (How to increase the test capacity for SARS-CoV-2 in Norway?)
ItalyDGFDM IT
Sede del Ministro – Ministero della salute
4/3/20VALidation of SARS-CORona Virus-2 assays - VALCOR project (End of project: 30.09.2021)
BelgiumIPH - Scientific Institute of Public Health (sciensano)4/1/20VALidation of SARS-CORona Virus-2 assays - VALCOR project (End of project: 30.09.2021)
SwedenMPA Medical Products Agency4/1/20Snabb- och självtester för covid-19 (Quick and self tests for covid-19)
CroatiaMIZ
Ministry of Health of the Republic of Croatia
3/31/20Uzimanje uzoraka za testiranje na SARS-CoV-2 (Sampling for testing on SARS-CoV-2 - Instructions)
NorwayHdir3/28/20Testkapasitet for Covid-19 sykdom (Test capacity for Covid-19 disease)
UKNICE
National Institute for Health and Care Excellence
3/24/20COVID-19 rapid evidence summary: acute use of nonsteroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19

 

This will be a ‘work in progress’ as we accrue data and as the response to Covid-19 evolves, so please bookmark this page for quick reference as we build out the links.

For any questions, please contact the EUnetHTA Secretariat at eunethta@zinl.nl